Fosun Pharma (02196) Announces Proposed Spin-off of Fosun Adgenvax

Bulletin Express02-04

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 02196) has issued a notice announcing plans for a first extraordinary general meeting on 27 February 2026 at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai. The agenda will focus on twelve special resolutions related to the proposed spin-off of Fosun Adgenvax and the listing of its H shares on the Main Board of the Hong Kong Stock Exchange.

Key resolutions include assessing the spin-off’s compliance with relevant laws, examination of the commercial rationale and feasibility, and ensuring the company’s independence and operating capability after the spin-off. The proposed plan also addresses the protection of shareholders’ and creditors’ rights, the completeness of statutory procedures, and the authorization to the board to handle all related matters. Additionally, an assured entitlements arrangement to the company’s H shareholders in connection with the spin-off is outlined in the resolutions.

The company has noted that voting on all resolutions is open to holders of overseas listed foreign shares (H Shares). Proxy forms and supporting documents must be submitted to the Hong Kong share registrar at least 24 hours before the meeting. Shareholders who submit proxy forms will retain the right to attend and vote at the meeting in person.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199145504?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199145504","market":"hk","top_or_hot":-1,"title":"Fosun Pharma (02196) Announces Proposed Spin-off of Fosun Adgenvax","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 02196) has issued a notice announcing plans for a first extraordinary general meeting on 27 February 2026 at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai. The agenda will focus on twelve special resolutions related to the proposed spin-off of Fosun Adgenvax and the listing of its H shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p>Key resolutions include assessing the spin-off’s compliance with relevant laws, examination of the commercial rationale and feasibility, and ensuring the company’s independence and operating capability after the spin-off. The proposed plan also addresses the protection of shareholders’ and creditors’ rights, the completeness of statutory procedures, and the authorization to the board to handle all related matters. Additionally, an assured entitlements arrangement to the company’s H shareholders in connection with the spin-off is outlined in the resolutions.</p>\n<p>The company has noted that voting on all resolutions is open to holders of overseas listed foreign shares (H Shares). Proxy forms and supporting documents must be submitted to the Hong Kong share registrar at least 24 hours before the meeting. Shareholders who submit proxy forms will retain the right to attend and vote at the meeting in person.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma (02196) Announces Proposed Spin-off of Fosun Adgenvax</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma (02196) Announces Proposed Spin-off of Fosun Adgenvax\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-04 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 02196) has issued a notice announcing plans for a first extraordinary general meeting on 27 February 2026 at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai. The agenda will focus on twelve special resolutions related to the proposed spin-off of Fosun Adgenvax and the listing of its H shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p>Key resolutions include assessing the spin-off’s compliance with relevant laws, examination of the commercial rationale and feasibility, and ensuring the company’s independence and operating capability after the spin-off. The proposed plan also addresses the protection of shareholders’ and creditors’ rights, the completeness of statutory procedures, and the authorization to the board to handle all related matters. Additionally, an assured entitlements arrangement to the company’s H shareholders in connection with the spin-off is outlined in the resolutions.</p>\n<p>The company has noted that voting on all resolutions is open to holders of overseas listed foreign shares (H Shares). Proxy forms and supporting documents must be submitted to the Hong Kong share registrar at least 24 hours before the meeting. Shareholders who submit proxy forms will retain the right to attend and vote at the meeting in person.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1199145504","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199145504","pubTimestamp":1770204288,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 02196) has issued a notice announcing plans for a first extraordinary general meeting on 27 February 2026 at 1:30 p.m., to be held at Sky...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"复星医药(02196)公布建议分拆复星Adgenvax","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (stock code: 02196) has issued a notice announcing plans for a first extraordinary general meeting on 27 February 2026 at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai. The agenda will focus on twelve special resolutions related to the proposed spin-off of Fosun Adgenvax and the listing of its H shares on the Main Board of the Hong Kong Stock Exchange.\nKey resolutions include assessing the spin-off’s compliance with relevant laws, examination of the commercial rationale and feasibility, and ensuring the company’s independence and operating capability after the spin-off. The proposed plan also addresses the protection of shareholders’ and creditors’ rights, the completeness of statutory procedures, and the authorization to the board to handle all related matters. Additionally, an assured entitlements arrangement to the company’s H shareholders in connection with the spin-off is outlined in the resolutions.\nThe company has noted that voting on all resolutions is open to holders of overseas listed foreign shares (H Shares). Proxy forms and supporting documents must be submitted to the Hong Kong share registrar at least 24 hours before the meeting. Shareholders who submit proxy forms will retain the right to attend and vote at the meeting in person.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199145504","isCrawlerRequest":true}